Form 4: U.S. Physical Therapy CFO Carey Hendrickson Reports Stock Sales

Sentiment:

SEC Form 4 Filing


Carey Hendrickson, CFO of U.S. Physical Therapy, reported selling shares of common stock on March 13, 2024.

Summary

  • Carey Hendrickson, the Chief Financial Officer of U.S. Physical Therapy Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On March 13, 2024, Hendrickson sold 12 shares of common stock at $107.23 per share and 1,788 shares at $107.28 per share.
  • Following these transactions, Hendrickson directly owns 21,186 shares of U.S. Physical Therapy Inc.
  • Included in these holdings are 15,368 shares granted as restricted stock under the company's Amended and Restated 2003 Stock Incentive Plan, which vest in installments through January 1, 2028, contingent upon continued employment.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to stock sales by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider transactions.

Industry Context

Form 4 filings are a routine part of insider trading activity and are closely watched by investors for signals about management's confidence in the company's prospects. While sales don't necessarily indicate a negative outlook, they can sometimes be interpreted as such.

Stakeholder Impact

  • Shareholders may interpret the stock sale as a signal, though it's a relatively small transaction.
  • The vesting schedule of the restricted stock incentivizes the CFO's continued employment with the company.

Key Dates

DateDescription
03/13/2024Date of stock sale transactions.
03/14/2024Date of signature on the Form 4 filing.
April 1, 2024First vesting date for restricted stock (1,438 shares).
July 1, 2024Second vesting date for restricted stock (1,438 shares).
October 1, 2024Third vesting date for restricted stock (1,446 shares).
January 1, 2025Fourth vesting date for restricted stock (1,209 shares).
April 1, 2025Fifth vesting date for restricted stock (1,208 shares).
July 1, 2025Sixth vesting date for restricted stock (1,208 shares).
October 1, 2025Seventh vesting date for restricted stock (1,208 shares).
January 1, 2026Eighth vesting date for restricted stock (1,221 shares).
April 1, 2026Ninth vesting date for restricted stock (740 shares).
July 1, 2026Tenth vesting date for restricted stock (740 shares).
October 1, 2026Eleventh vesting date for restricted stock (740 shares).
January 1, 2027Twelfth vesting date for restricted stock (747 shares).
April 1, 2027Thirteenth vesting date for restricted stock (506 shares).
July 1, 2027Fourteenth vesting date for restricted stock (506 shares).
October 1, 2027Fifteenth vesting date for restricted stock (506 shares).
January 1, 2028Final vesting date for restricted stock (507 shares).

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.